VF
STRO icon

Virtu Financial’s Sutro Biopharma STRO Stock Holding History

Virtu Financial’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,231
Closed -$77K – 2034
2024
Q3 		$77K Buy
+2,231
New +$87.5K ﹤0.01% 950
2024
Q2 		– Sell
-6,316
Closed -$357K – 1856
2024
Q1 		$357K Buy
6,316
+4,639
+277% +$205K 0.03% 542
2023
Q4 		$72K Buy
+1,677
New +$53.2K 0.01% 1103

Other funds holding STRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Virtu Financial's STRO Position: Q4 2024 in Review

Virtu Financial sold out of Sutro Biopharma (STRO) in Q4 2024, closing a stake of 2,231 shares — an estimated $77K sold.

Virtu Financial first reported a position in STRO in Q4 2023 and held it in 3 quarters. The position peaked at $357K in Q1 2024. 122 funds tracked by Wall St. Rank hold STRO as of Q4 2024.

  • Virtu Financial reported no remaining Sutro Biopharma position as of Q4 2024 after selling out during the quarter.
  • Virtu Financial sold 2,231 Sutro Biopharma shares in Q4 2024, an estimated $77K.
  • Virtu Financial first reported a position in Sutro Biopharma in Q4 2023 and held it in 3 quarters.
  • Virtu Financial's Sutro Biopharma position peaked at $357K in Q1 2024.
  • 122 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.